[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-268923-105":59,"doc-detail-268923-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","kidney-health-evaluation-for-patients-with-diabetes-ked-hedis-measure-effectiveness-of-care","Kidney Health Evaluation for Patients with Diabetes (KED) - HEDIS® Measure - Effectiveness of Care","","Kidney Health Evaluation for Patients with Diabetes (KED) summarizes the HEDIS® measure that tracks the percentage of diabetic patients who receive kidney health evaluation. The document defines the measure population, required diabetes encounter or pharmacy criteria, and the numerator requirements for eGFR and urine albumin creatinine ratio (uACR) testing. It lists clinical and service-based exclusions, offers coding and compliance tips to close the measure, and provides key CPT/lab test codes and resources for reference.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/kidney-health-evaluation-for-patients-with-diabetes-ked-hedis-measure-effectiveness-of-care/268923/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/kidney-health-evaluation-for-patients-with-diabetes-ked-hedis-measure-effectiveness-of-care/268923.png","ImageObject",300,407,{"name":92,"@type":93},"Stanley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-22","2026-09-15",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",17,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What patient group is included in the KED measure population?","Question",{"text":113,"@type":114},"The measure population includes patients aged 18–85 with diabetes (Type 1 or Type 2), identified through encounter diagnoses or pharmacy data during the measurement year or the year prior.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How is measure compliance (numerator) determined for KED?",{"text":118,"@type":114},"Compliance requires both serum eGFR and urine albumin creatinine ratio (uACR) identified using the specified urine albumin/creatinine testing approach or a uACR test using LOINC codes only.",{"name":120,"@type":111,"acceptedAnswer":121},"Which situations exclude a patient from the KED measure?",{"text":122,"@type":114},"Exclusions include advanced illness and frailty in specific age ranges, hospice and palliative care during the measurement year, frailty at age 81+, and history of ESRD or dialysis, as well as deceased patients during the measurement year.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},268923,1789438997,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":81,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":130,"read_time":39},2336477405376,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Kidney Health Evaluation for Patients with Diabetes (KED)  \nEffectiveness of Care HEDIS® Measure  \nMeasurement description  \nPercentage of diabetic patients who received a kidney health evaluation.  \nMeasure population (denominator)  \nPatients 18-85 years old with diabetes (Type 1 or Type 2).  \nEither of the following during the measurement year or the year prior to the measurement year:  \n• Encounter data: at least two diagnoses of diabetes on different dates of service  \n• Pharmacy data: dispensed insulin or hypoglycemics/antihyperglycemics AND have at least one diagnosis of diabetes  \nDiabetes medications  \nAlpha-glucosidase inhibitors  \nInsulin  \nGlucagon-like peptide-I (GLP I) agonists  \n| Antidiabetic\u003Cbr>combinations | Biguanides |\n| --- | --- |\n| Sulfonylureas | Thiazolidinediones |\n\nSodium glucose cotransporter 2 (SGLT2) inhibitor  \ncontinued  \nStar Measure Tips  \nOne in a series of tip sheets that look at key Healthcare Effectiveness Data and Information Set measures, commonly referred to as  \nHEDIS® measures.  \nDid you know?  \n• Diabetes and high blood pressure are the most common causes of kidney disease.  \n• Adequate control of blood sugar and blood pressure have been shown to lower the risk of developing kidney disease.  \n• Kidney disease often develops slowly, consequently many are unaware until the disease is advanced and requires dialysis or a kidney transplant.  \n• Kidney disease is more common in women, people over 65, as well as Black and Hispanic adults.  \nMeasure compliance (numerator)  \nDiabetic patients who received both of the following during the measurement year:  \n1. Serum estimated glomerular filtration rate (eGFR)  \n2. Urine albumin creatinine ratio (uACR) identified by either of the following:  \n− Both a quantitative urine albumin test and a urine creatinine test from the same urine sample Or  \n− Urine albumin creatinine ratio test (uACR). Closed by LOINC codes only.  \nExclusions  \n• Are age 66–80 with advanced illness and frailty (for additional definition information, see the Advanced Illness and Frailty Guide)  \n• Received hospice services anytime during the measurement year  \n• Are age 81 or older with frailty (for additional definition information, see the Advanced Illness and Frailty Guide).  \n• Received palliative care during the measurement year  \n• End stage renal disease (ESRD) or dialysis anytime during the patient’s history  \n• Deceased during the measurement year Helpful HEDIS hints  \n• If using an in-office analyzer for urine testing, be sure to confirm the type of urine albumin test that is performed. Some analyzers only measure semi-quantitative urine albumin, require a different CPT code, and will not close this measure.  \n• Lab test reports should indicate both an eGFR and uACR were performed during the measurement year on the same or different dates of service.  \n• Order labs to be completed prior to patient appointments.  \n• Ensure labs are ordered at least annually, preferably at the beginning of the year.  \n• Educate patients about the importance of routine screening and medication compliance.  \n• Review diabetic services needed at each office visit.  \n• When ordering the urine test, be sure that the albumin and creatinine values are being measured, reported, and both codes are being billed (82043, 82570).  \nTips for coding  \nTo ensure gap closure, verify the practitioner orders and lab facilities include all three tests below: Note: Measure can only be closed through claims or EMR supplemental data feed.  \n| CPT® code | Laboratory Test |\n| --- | --- |\n| 80047, 80048, 80050, 80053, 80069, 82565 | Estimated Glomerular Filtration Rate Lab Test (eGFR) |\n| 82043 | Quantitative Urine Albumin Test |\n| 82570 | Urine Creatinine Lab Test |\n\nDocument and bill exclusions annually (see the Advanced Illness and Frailty Guide for details).  \nResources  \n1. Centers for Disease Control and Prevention (CDC). 2024.“Chronic Kidney Disease.” [cdc.gov/](cdc.gov/)[ ](cdc.gov/)[diabetes/diabetes-co","cbCaieVLh86o6E0S","https://ap.wps.com/l/cbCaieVLh86o6E0S","pdf",319295,"English","# Measure description\n# Measure population (denominator)\n## Diabetes medication and identification criteria\n# Measure compliance (numerator)\n## Required tests: eGFR and uACR\n# Exclusions\n# Helpful HEDIS hints\n# Tips for coding\n# Resources","[{\"question\":\"What patient group is included in the KED measure population?\",\"answer\":\"The measure population includes patients aged 18–85 with diabetes (Type 1 or Type 2), identified through encounter diagnoses or pharmacy data during the measurement year or the year prior.\"},{\"question\":\"How is measure compliance (numerator) determined for KED?\",\"answer\":\"Compliance requires both serum eGFR and urine albumin creatinine ratio (uACR) identified using the specified urine albumin/creatinine testing approach or a uACR test using LOINC codes only.\"},{\"question\":\"Which situations exclude a patient from the KED measure?\",\"answer\":\"Exclusions include advanced illness and frailty in specific age ranges, hospice and palliative care during the measurement year, frailty at age 81+, and history of ESRD or dialysis, as well as deceased patients during the measurement year.\"}]","Kidney Health Evaluation for Patients with Diabetes (KED) - HEDIS® Measure - Effectiveness of Care | PDF"]